Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Enliven Therapeutics, Inc. Common Stock (ELVN)

Pharmaceutical Preparations

https://www.enliventherapeutics.com

Enliven Therapeutics Inc is a clinical-stage precision oncology company focused on the discovery and development of potentially best-in-class or first-in-class precision oncology therapies. Enliven's programs are designed to address issues such as tolerability, combinability, resistance and disease escape through brain metastases.

6200 LOOKOUT ROAD
BOULDER, CO

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

02/24/2023

Market Cap

1,138,888,892

Shares Outstanding

41,210,000

Weighted SO

41,211,973

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

THRX --.--%

PMVP --.--%

CGEM --.--%

IMRX --.--%

AVTE --.--%

MLTX --.--%

GPCR --.--%

CMPX --.--%

REPL --.--%

Beta

0.9310

Last Div

0.0000

Range

9.8-27.673

Chg

0.3400

Avg Vol

291922

Mkt Cap

1138888892

Exch

NASDAQ

Country

US

Phone

720 647 8519

DCF Diff

21.0607

DCF

2.8093

Div Yield

0.0000

P/S

2588.3838

EV Multiple

-10.7156

P/FV

3.8011

Div Yield %

0.0000

P/E

-13.9941

PEG

-0.1679

Payout

0.0000

Current Ratio

14.3916

Quick Ratio

14.3916

Cash Ratio

4.3848

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

1258.9013

CCC

-1258.9013

Gross Margin

0.2864

Op Margin

-221.7432

Pretax Margin

-187.7159

Net Margin

-188.2432

Eff Tax Rate

-0.0238

ROA

-0.2533

ROE

-0.2931

ROCE

-0.3200

NI/EBT

1.0028

EBT/EBIT

0.8465

EBIT/Rev

-221.7432

Debt Ratio

0.0005

D/E

0.0006

LT Debt/Cap

0.0000

Total Debt/Cap

0.0006

Int Coverage

-57.5956

CF/Debt

-427.0533

Equity Multi

1.0725

Rec Turnover

0.0000

Pay Turnover

0.2899

Inv Turnover

0.0000

FA Turnover

0.5563

Asset Turnover

0.0013

OCF/Share

-1.5012

FCF/Share

-1.5023

Cash/Share

6.4991

OCF/Sales

-164.0273

FCF/OCF

1.0007

CF Coverage

-427.0533

ST Coverage

-427.0533

CapEx Coverage

-1387.9231

Div&CapEx Cov

-1387.9231

P/BV

3.8011

P/B

3.8011

P/S

2588.3838

P/E

-13.9941

P/FCF

-15.7688

P/OCF

-16.0601

P/CF

-16.0601

PEG

-0.1679

P/S

2588.3838

EV Multiple

-10.7156

P/FV

3.8011

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Sep 28, 13:35 Enliven Therapeutics Announces Positive Data Update from Phase 1 Clinical Trial of ELVN-001 in Chronic Myeloid Leukemia

Revenue Product Segmentation